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Abstract
Background: In vertebrates, the inner ear is comprised of the cochlea and vestibular system,
which develop from the otic vesicle. This process is regulated via inductive interactions from
surrounding tissues. Tbx1, the gene responsible for velo-cardio-facial syndrome/DiGeorge
syndrome in humans, is required for ear development in mice. Tbx1 is expressed in the otic
epithelium and adjacent periotic mesenchyme (POM), and both of these domains are required for
inner ear formation. To study the function of Tbx1 in the POM, we have conditionally inactivated
Tbx1 in the mesoderm while keeping expression in the otic vesicle intact.
Results: Conditional mutants (TCre-KO) displayed malformed inner ears, including a hypoplastic
otic vesicle and a severely shortened cochlear duct, indicating that Tbx1 expression in the POM is
necessary for proper inner ear formation. Expression of the mesenchyme marker Brn4 was also
lost in the TCre-KO. Brn4-;Tbx1+/-embryos displayed defects in growth of the distal cochlea. To
identify a potential signal from the POM to the otic epithelium, expression of retinoic acid (RA)
catabolizing genes was examined in both mutants. Cyp26a1 expression was altered in the TCre-KO,
while Cyp26c1 showed reduced expression in both TCre-KO and Brn4-;Tbx1+/- embryos.
Conclusion: These results indicate that Tbx1 expression in the POM regulates cochlear
outgrowth potentially via control of local retinoic acid activity.
Background
The vertebrate inner ear develops from the otic vesicle,
which forms via invagination of specified ectodermal cells
adjacent to the hindbrain. A crucial phase in development
of the sensory structures of the inner ear occurs as the otic
epithelium acquires regional identity along its axes. Clas-
sic explant experiments by developmental biologists first
suggested that otic patterning occurred in response to sig-
nals from surrounding tissues, and recent work has
revealed much of the molecular basis of these interactions
[for review see [1-3]]. For example, genetic studies in the
mouse showed that genes expressed along the dorsoven-
tral axis of the otic vesicle are induced by signals from the
roof plate and floor plate of the neural tube [4,5]. Specifi-
cally, members of the Wnt family of morphogens, secreted
from the dorsal hindbrain, regulate the expression of dor-
sal genes required for development of vestibular struc-
tures, while Sonic hedgehog (Shh) secreted from the
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expression of ventral genes that promote cochlear forma-
tion.
Proper patterning of the otic vesicle is essential for subse-
quent growth and morphogenesis of the inner ear. In the
ensuing stages of development, genes expressed within
the otic vesicle are known to direct formation of the coch-
lea and vestibular structures. However, surrounding tis-
sues continue to play an important role. Shh promotes
outgrowth of the cochlear duct via activation of Gli2 and
Gli3 in the otic vesicle and surrounding mesenchyme [6].
In addition, periotic mesenchyme (POM) cells condense
around the otic vesicle and undergo chondrogenesis to
give rise to the otic capsule, which surrounds and protects
the inner ear sensory structures. The close association
between the POM and the otic epithelium suggests that
epithelial-mesenchymal interactions exist between these
two tissues, and disruption of these interactions could
lead to defects in inner ear formation. Indeed, multiple
mouse mutants indicate that signaling from the epithe-
lium to the mesenchyme is crucial for capsule formation
and is dependent upon members of the Fibroblast growth
factor (Fgf) and Bone morphogenic protein (Bmp) gene fam-
ilies [7-9].
Evidence supporting a requirement for signals from the
POM to the otic vesicle during inner ear formation also
exists. Explant experiments demonstrated that cultured
otic vesicle epithelium failed to form differentiated hair
cells in the absence of surrounding POM cells [10,11].
Furthermore, mice null for Brn4, a Pou-domain transcrip-
tion factor expressed in the POM but not the otic vesicle,
display a reduction in the number of turns of the cochlea
[12]. These data indicate a cell nonautonomous role for
the POM during inner ear development.
TBX1 is a member of a large family of transcription factors
called T-box genes that have important roles in embryonic
development. Haploinsufficiency of TBX1 in humans is
associated with velo-cardio-facial syndrome/DiGeorge
syndrome (VCFS/DGS), which causes sensorineural hear-
ing loss in approximately 10% of patients [13]. In the
mouse, Tbx1 is essential for the development of the inner
ear, evidenced by the lack of both auditory and vestibular
structures as well as an expansion of the cochleovestibular
ganglion (CVG) in Tbx1 null mutants [14,15]. During
embryogenesis, Tbx1 is expressed in both in the otic vesi-
cle and in the ventral POM cells that lie between the
source of Shh and the otic vesicle. Conditional ablation of
Tbx1 expression in the otic vesicle results in an inner ear
phenotype identical to that of Tbx1-/- embryos, indicating
a tissue autonomous role for Tbx1 in otic vesicle pattern-
ing [16]. However, the POM domain of Tbx1 was also
shown to be essential for normal outgrowth of the coch-
lear duct, supporting a role for the mesenchyme in mor-
phogenesis of the inner ear epithelium [17].
These data support a model in which cochlear outgrowth
is regulated by Shh signaling from the ventral midline via
genes expressed in the POM and the otic vesicle. Expres-
sion of both Tbx1 and Brn4 in the POM is responsive to
Shh signaling, and is lost in Shh null mutants [4]. In con-
trast, Tbx1 expression in the otic vesicle is unaffected in
Shh-/- embryos [4,18]. This indicates that the mechanism
by which Shh regulates cochlear duct outgrowth may be
distinct from its regulation of otic vesicle patterning.
To further characterize the role of the POM in inner ear
morphogenesis and identify genes downstream of Tbx1
and Brn4 signaling to the otic vesicle, we generated
mutants in which Tbx1 was specifically ablated in the mes-
oderm. T-Cre mediated conditional mutants (TCre-KO)
displayed severe defects in growth and coiling of the coch-
lear duct, similar to a comparable Tbx1 mutant using an
alternative Cre driver [17]. To determine the molecular
basis for these defects, Brn4 protein expression was exam-
ined in TCre-KO mutants, since adult Brn4-;Tbx1+/- mice
also display a reduction in the number of cochlear turns
[19]. Expression of Brn4 was lost in the POM in condi-
tional mutants, and Brn4-;Tbx1+/- embryos exhibited simi-
lar but less severe defects in cochlear coiling compared to
TCre-KO embryos. Further, expression of retinoic acid
(RA) metabolizing enzymes was examined because RA
has been implicated in the control of epithelial-mesen-
chymal interactions [20]. We identified changes in the
expression of RA catabolizing enzymes Cyp26a1 and
Cyp26c1 in both TCre-KO and Brn4-;Tbx1+/-mutants. These
results support a role for Tbx1 and Brn4 in regulating lev-
els of RA in the POM required for inner ear morphogene-
sis.
Results
The inner ears of TCre-KO embryos are malformed
To assess the role of Tbx1 in the POM, conditional
mutants were created in which Tbx1 expression was
ablated in all mesodermal tissues. This mutant was gener-
ated by crossing mice carrying the Tbx1flox allele with T-Cre
transgenic mice to obtain T-Cre;Tbx1flox/- embryos (TCre-
KO). To confirm that Cre activity was restricted to the mes-
oderm, T-Cre mice were crossed with the ROSA26 reporter
strain [21] and offspring were analyzed for LacZ expres-
sion. At E9.0 and E10.5, Cre activity was detected in the
mesodermal cells surrounding the otic vesicle and not in
the otic epithelium (Additional file 1, Fig. S1A, B). Analy-
sis of Tbx1 expression at E9.5 and E10.5 in TCre-KO
embryos revealed reduced Tbx1 expression in the meso-
derm compared to control (Tbx1+/-) embryos, while Tbx1
expression in the otic vesicle was unaffected (Additional
file 1, Fig. S1C-F). Analysis of TCre-KO embryos using anPage 2 of 12
(page number not for citation purposes)
BMC Developmental Biology 2009, 9:31 http://www.biomedcentral.com/1471-213X/9/31anti-Tbx1 antibody (Ab) confirmed that the residual Tbx1
expression was not due to an aberrant transcript (data not
shown). These data indicated that the TCre-KO mutant
was a mesodermal hypomorph. Supporting this, TCre-KO
mutants displayed a phenotype that closely matched
another Tbx1 mesodermal conditional mutant generated
using the Mesp1-Cre driver [22]. Analysis of the inner ear
of both mutants by paint-fill (n = 6) revealed slightly var-
iable but overlapping phenotypes, however the most
severely affected inners ear of TCre-KO embryos displayed
a shorter cochlear duct than Mesp1Cre-KO mutants (Addi-
tional file 2, Fig. S2A-D). Mesp1Cre-KO mutants were also
found to be hypomorphic following examination of Tbx1
expression (Additional file 2, Fig. S2E-F). Thus, mesoder-
mal expression of Tbx1 in the TCre-KO mutant appears to
be reduced to a level sufficient to isolate the role of Tbx1
in the POM.
Examination of the membranous labyrinth of TCre-KO
embryos revealed multiple defects. The cochlea normally
forms one and three quarter turns in the mouse by E15.5
(Fig. 1A). At this stage, 4 of 6 TCre-KO embryos displayed
a severely shortened cochlea with only the most basal, or
hook region, present (Fig. 1D, Additional file 2 – Fig.
S2B). Two TCre-KO embryos displayed an abnormal but
slightly longer cochlea (Additional file 2, Fig. S2A). The
vestibular system exhibited consistent mild hypoplasia,
however the semicircular canals, utricle and saccule were
always present. In addition, the endolymphatic duct and
sac were enlarged (Fig. 1D), reminiscent of Mondini dys-
plasia. Histological sections through the inner ear of TCre-
KO embryos at E17.5 (n = 8) confirmed the cochlear
defects seen by paint-fill and revealed a lack of a recogniz-
able organ of Corti (Fig. 1B and 1E). This is consistent
with the sensory organ defects reported in Mesp1Cre-KO
mutants, which displayed a lack of hair cells in the medial
and apical cochlea evidenced by the absence of Myosin 7a
expression [17]. In addition, TCre-KO embryos displayed
abnormalities in the structure of the otic capsule (Fig. 1B,
E). Interestingly, the capsule surrounding the vestibular
system appeared relatively unaffected, while the cochlear
capsule was severely malformed. This was easily appreci-
ated upon bone and cartilage staining of TCre-KO
embryos (n = 5; Fig. 1C, F). The capsule malformations
may be due to defects in the POM, or secondary to the
malformations of the membranous labyrinth.
Otic patterning appears unaffected in TCre-KO mutants
Ventral structures of the inner ear in TCre-KO embryos
were more severely affected than dorsal structures, consist-
ent with the localization of Tbx1 expression in the ventral
POM during inner ear morphogenesis (Additional file 1,
Fig. S1C). Because Shh is known to regulate the expression
of ventral markers in the otic vesicle, we speculated that
patterning of the dorsoventral axis might be abnormal in
TCre-KO embryos. Analysis of ventral sensory markers
Pax2 and Otx1 and dorsal markers Bmp4 and Dlx5
revealed no changes in expression in the otic vesicle of
TCre-KO embryos versus controls at E10.5 (n = 3, Fig. 2A–
D). This suggests that early dorsoventral patterning occurs
normally in the absence of mesodermal Tbx1. In addition,
expression of Gata3, a lateral marker, as well as anterior
markers NeuroD, Fgf10, Fgf3 and Lnfg, was unchanged in
TCre-KO mutants compared to controls at E10.5 (n = 3,
Fig. 2E–J). Lmx1a, which has been shown to be required
for development of the endolymphatic duct [23], is also
unchanged in TCre-KO embryos at this stage (n = 3, Fig.
2K, K'). This indicates that early otic patterning and for-
mation of the CVG are likely unaffected in TCre-KO
mutants. This is consistent with the reported normal
expression of neurogenic markers Isl1 and Ngn1 in
Mesp1Cre-KO embryos at the same stage [24].
To ascertain the stage in which changes in gene expression
might first appear in the TCre-KO mutants, we identified
the onset of morphological defects in mutant embryos. At
E10.5, the otic vesicles of TCre-KO embryos were indistin-
guishable in overall size and shape from control otic vesi-
cles (n = 4; Fig. 2L, L'), consistent with the lack of
expression changes of molecular markers. However, at
E11.5 TCre-KO embryos exhibited a malformed and
hypoplastic otic vesicle that was easily distinguished from
controls (n = 9; Fig. 2M, M'). Thus, physical defects in the
otic vesicles TCre-KO embryos do not appear until after
axis determination is complete, consistent with a role for
Tbx1 expression in the POM in otic patterning.
TCre-KO embryos display defects in cell proliferation and 
survival
Tbx1 has previously been shown to regulate the mitotic
activity of the otic epithelium [24], indicating the abnor-
mal inner ears seen in TCre-KO embryos may be due to
defects in cell proliferation. To test this hypothesis,
mutant and control embryos were analyzed at E11.5 using
an antibody to the M-phase marker phospho-Histone 3
(Fig. 3A, C). This stage was chosen because it corresponds
with the onset of morphological defects in the otic vesicle
of TCre-KO embryos. Proliferating cells were counted in
transverse sections through the entire otic vesicle of
mutant and control embryos (n = 6). A significant reduc-
tion in proliferating cells was apparent (p = 0.011, Stu-
dent's t-test), with an average of 25.9 and 42.7 positive
cells per section in mutant versus control, respectively
(Fig. 3E). Proliferating cells were also counted in the dor-
sal and ventral halves of the otic vesicle, and both of these
regions displayed a decrease in proliferation in mutant
compared to control embryos (Fig 3E, n = 6, p = 0.001
dorsal and p = 0.038 for ventral). Interestingly, no signifi-Page 3 of 12
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and ventral halves of the TCre-KO mutants were com-
pared directly (Fig. 3E). This suggests that cell prolifera-
tion is reduced broadly throughout the entire otic vesicle,
as opposed to a localization of defects in the dorsal or ven-
tral epithelium. We next tested whether proliferation of
POM cells was affected in TCre-KO mutants. At E11.5, the
cells of the POM have only just begun to condense around
the otic vesicle and have not yet formed a well-defined
population. We assessed cell proliferation in the POM of
TCre-KO embryos by counting positive cells in an arbitrar-
ily defined region of mesenchyme surrounding the otic
vesicle. Proliferation was found to be unaffected in TCre-
KO embryos compared to controls (n = 4, 77.3 and 74.6
positive cells per section in mutant and controls, respec-
tively), suggesting that Tbx1 does not exert a tissue auton-
omous affect on proliferation of POM cells at this stage.
We next asked whether the otic epithelium of TCre-KO
embryos displayed changes in cell survival using an anti-
body to the apoptotic marker activated Caspase 3. At
E11.5, a significant increase in cell death was observed in
the otic vesicle of TCre-KO embryos compared to controls
(p = 0.035, Student's t-test, n = 4), with an average of 7.02
and 4.13 apoptotic cells per section in mutant versus con-
trol embryos, respectively (Fig. 3B, D, F). This indicates
that Tbx1 expression in the POM has a modest affect on
survival of the otic epithelium. Interestingly, apoptotic
cells were not observed in the POM of TCre-KO or control
embryos at this stage (Fig. 3B, D). These data suggest that
Tbx1 has a role in regulating paracrine signaling to the otic
epithelium prior to capsule formation.
Tbx1 and Brn4 interact in the POM
A previous study showed that protein expression of Brn4,
a marker for the POM, was lost in Tbx1 null mice but
present in conditional mutants in which Tbx1 was ablated
in the otic vesicle and pharyngeal endoderm [16]. This
suggested that the POM domain of Tbx1 regulates Brn4 or
proliferation of Brn4-expressing cells. To test this hypoth-
esis, Brn4 expression was examined in TCre-KO embryos
and was indeed reduced in the POM at E10.5 (Fig. 4A–D,
n = 3).
We recently established a genetic interaction between
Tbx1 and Brn4 in the inner ear, as adult Brn4-;Tbx1+/- mice
display a significant reduction in the number of cochlear
turns compared to Brn4- or Tbx1+/- mice alone [19]. To
determine the morphological basis of this interaction, the
membranous labyrinth of compound mutants of Tbx1
and Brn4 was analyzed by paint-fill experiments. At E15.5,
all Tbx1+/- (n = 6) and Brn4+/-;Tbx1+/- (n = 6) embryos
exhibited grossly normal inner ear structures (Fig. 4E, F).
Furthermore, the majority of Brn4- mutants (Brn4 is X-
linked) also exhibited normal inner ears with a com-
pletely coiled cochlea (8 out of 10 inner ears examined;
Fig. 4G). Two Brn4- mice displayed a slightly shortened
cochlea of 1.5 turns (Fig. 4H). We then asked whether the
addition of a single Tbxl null allele would affect the pene-
trance of the Brn4 null phenotype. All Brn4-;Tbx1+/-
mutants (n = 10) exhibited one cochlear turn followed by
abnormal twisting and termination of the cochlear duct
(Fig. 4I). In some cases, the cochlear duct bifurcated
before terminating prematurely (Fig. 4J). These data indi-
cate that Tbx1 may function in parallel with Brn4 to regu-
Inner ear defects in the TCre-KOFigur  1
Inner ear defects in the TCre-KO. At E15.5, a paint-filled 
inner ear of a control embryo (A) displays a cochlea (c) con-
sisting of 1.75 turns and a vestibular system consisting of the 
saccule (s), utricle (u), endolymphatic duct (ed) and lateral, 
posterior and superior semicircular canals (lsc, psc, ssc). A 
transverse section though the inner ear of an E17.5 control 
embryo (B) displays the sensory structures of the ear with an 
intact organ of Corti (bracketed in inset) and the surround-
ing capsule. Bone and cartilage staining of an E17.5 control 
embryo (C) reveals the vestibular capsule (vc) and cochlear 
capsule (cc). Paint-fill of the inner ear of an E15.5 TCre-KO 
embryo (D) reveals malformations of both the auditory and 
vestibular system. The cochlea is severely shortened, the 
vestibular structures are hypoplastic and the endolymphatic 
duct (which did not completely fill with paint in (A)) is 
enlarged. At E17.5, the inner ears of TCre-KO embryos (E) are 
malformed and display only the hook region of the cochlea 
(c) with no recognizable organ of Corti (inset), and hypoplas-
tic semicircular canals (lsc, ssc). Bone and cartilage staining 
(F) reveals a malformed cochlear capsule (cc), while the ves-
tibular capsule (vc) appears relatively unaffected. Scale bar in 
B is 200 μm.Page 4 of 12
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cochlear growth.
Tbx1 regulates RA metabolism in the POM
The defects seen in TCre-KO and Brn4-;Tbx1+/- embryos
suggest a non-autonomous role for Tbx1 and Brn4 in the
POM during cochlear outgrowth. Because both genes are
nuclear transcription factors, they may act on a common
downstream target that signals to the otic vesicle. One
likely candidate is retinoic acid (RA), which is known to
be important for epithelial-mesenchymal interactions
during inner ear development [20]. Tbx1-/- embryos carry-
ing a RA response element reporter construct [25] exhib-
ited increased RA activity in the pharyngeal mesenchyme,
including the POM, at E9.5 and E10.5 [26]. Further,
expression of Cyp26 enzymes that catabolize active RA
was reduced in these same tissues in Tbx1-/- embryos
[26,27]. We hypothesized that the inner ear defects
present in the TCre-KO mutant might be due to abnormal
RA metabolism caused by a reduction of Cyp26 gene
expression. Of the three Cyp26 genes that catabolize RA,
both Cyp26a1 and Cyp26c1 are co-expressed with Tbx1 in
the POM [27]. To test if mesenchymal Tbx1 regulates these
genes, expression analysis was performed on TCre-KO
embryos.
Cyp26a1 and Cyp26c1 are expressed in similar patterns in
the inner ear [28]. Both genes are restricted to the lateral
and ventral POM at E10.5 and E11.5, which corresponds
to the mesenchymal cells adjacent to the developing coch-
Otic markers and vesicle morphology are unaffected at E10.5 in TCre-KO mutantsFigure 2
Otic markers and vesicle morphology are unaffected at E10.5 in TCre-KO mutants. Expression of sensory (A-F) and 
neurogenic (G-J) markers are unchanged in TCre-KO embryos compared to controls at E10.5. Ventral markers Pax2 and Otx1, 
as well as dorsal markers Bmp4 and Dlx5 are normal in TCre-KO mutants (A'-D'). Gata3 expression in the lateral otic vesicle is 
also unchanged in the TCre-KO, visualized in cross sections through the otic vesicle (F'). Expression of anterior markers NeuroD, 
Fgf3, Lnfg and Fgf10 display normal expression in the CVG in both mutants (G'-J') and controls (G-J). Expression of Lmx1a, 
which marks the growing endolymphatic duct, is also unchanged (K, K'). Microdissected otic vesicles are shown at E10.5 (L, L') 
and E11.5 (M, M'). At E10.5, the morphology of the otic vesicle in control (L) and TCre-KO (L') embryos is similar. By E11.5, the 
otic vesicles of TCre-KO embryos (M') are malformed and hypoplastic compared to controls (M). Scale bar in L is 250 μm and 
applies to all panels except (E, E') and (F, F'). Scale bars in E' and F' are 200 μm.Page 5 of 12
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the lateral wall of the cochlear duct epithelium (Fig. 5M,
N). The expression of these genes in the POM significantly
overlaps with Tbx1 expression at these stages (compare
Additional file 2, Fig. S2E to Fig. 5A, E). At E10.5 in TCre-
KO embryos, Cyp26a1 expression was missing from the
lateral POM and appeared to be shifted to a more ventral
position (Fig. 5A, C, n = 3). Transverse sections through
the otic vesicle confirmed the absence of Cyp26a1 expres-
sion in the lateral POM (Fig. 5B, D). Further, expression of
Cyp26c1 was strongly reduced in the mesenchyme at
E10.5 in TCre-KO mutants, while first arch expression was
unaffected (Fig. 5E, G, n = 3). The reduction of Cyp26c1
expression is particularly evident in the POM immediately
posterior to the otic vesicle (Fig. 5F, H). Expression of
Cyp26b1, which is predominately in the dorsal POM, was
unchanged in TCre-KO mutants (data not shown).
The shift of Cyp26a1 expression from a lateral to a medial
position was also apparent at E11.5 in TCre-KO embryos
compared to controls (Fig. 5I–L, n = 3). This change in
expression was more pronounced in posterior sections
through the developing cochlear duct (Fig. 5J, L). Also at
this stage, Cyp26c1 expression was strongly reduced in the
TCre-KO embryos exhibit defects in cell proliferation and survivalFigure 3
TCre-KO embryos exhibit defects in cell proliferation and survival. Transverse sections at E11.5 of control (A) and 
TCre-KO (C) embryos labeled for mitotic cells using an Ab against phospho-Histone 3. TCre-KO embryos display a decrease in 
cell proliferation in the otic epithelium compared to controls upon quantification (E). Proliferation was reduced in both dorsal 
and ventral regions of the otic vesicle, but not in the POM. For the dorsal otic vesicle, 11.2 and 21.4 positive cells were 
observed for mutant and control, respectively, while 14.0 and 22.4 positive cells were observed observed for the ventral otic 
vesicle. TCre-KO embryos exhibit an increase in apoptosis at E11.5, identified by an Ab to active Caspase 3 (B, D). Arrow and 
bracketed area in (d) mark apoptotic cells. Quantification of apoptotic cells in control and mutant otic epithelium is shown (F). 
Asterisks indicate significant difference (* = p < 0.05, ** = p < 0.01, one-tailed, unpaired Student's t-test). Error bars represent 
95% confidence interval. Boxed areas are magnified in a-d. Scale bar indicates 200 μm in (A), and 50 μm in (a).Page 6 of 12
(page number not for citation purposes)
BMC Developmental Biology 2009, 9:31 http://www.biomedcentral.com/1471-213X/9/31ventral POM of TCre-KO mutants, while expression in the
cochlear duct epithelium was unaffected (Fig. 5M–P, n =
3).
This data suggests that Tbx1 acts upstream of two Cyp26
genes expressed in the medial and ventral POM. To fur-
ther test this hypothesis, expression of Cyp26a1 and
Cyp26c1 was analyzed in Tbx1+/-, Brn4- and Brn4-;Tbx1+/-
embryos. If Brn4 and Tbx1 both act upstream of a com-
mon target in the POM, then Brn4-;Tbx1+/- embryos might
display a similar change in Cyp26a1 and Cyp26c1 expres-
sion as seen in TCre-KO embryos. In Tbx1+/-, Brn4- and
Brn4-;Tbx1+/- embryos at E12.5, expression of Cyp26a1 was
unchanged (data not shown). However, Cyp26c1 expres-
sion was reduced in the ventral POM of Brn4-;Tbx1+/-
embryos compared to Tbx1+/- and Brn4- embryos (Fig. 6A–
C, E–F). Further, Cyp26c1 is co-expressed with Tbx1 in the
ventral POM surrounding the cochlear duct at this stage
(Fig. 6A, D). Together with the results seen in TCre-KO
mutants, these data indicate that Cyp26c1 is more sensi-
Brn4 expression is reduced in the POM of TCre-KO embryos, and Brn4-;Tbx1+/- embryo display defects in cochlea coilingFigure 4
Brn4 expression is reduced in the POM of TCre-KO embryos, and Brn4-;Tbx1+/- embryo display defects in coch-
lea coiling. Sagittal sections of control (A) and TCre-KO (B) embryos at E10.5 stained with an Ab against Brn4. Expression in 
the POM is lost in TCre-KO embryos, however neural tube (nt) expression is unaffected. Brn4-;Tbx1+/- embryos display a short-
ened cochlear duct. Lateral views of paint-filled membranous labyrinths at E15.5–E16.0 of Tbx1+/- (E), Brn4+/-;Tbx1+/- (F), Brn4-
(G, H), Brn4-;Tbx1+/- (I, J). The fully developed mouse cochlea normally completes 1.75 turns, and all inner ears of Tbx1+/- 
mutants and Brn4+/-;Tbx1+/- exhibited normal cochlear growth (E, F). The majority of Brn4- mutant inner ears also displayed a 
normal cochlea (G), while 20% displayed a slightly shortened cochlea (H). All inner ears Brn4-;Tbx1+/- mutants exhibited a mal-
formed cochlea that failed to form a second turn and instead displayed abnormal twisting or bifurcation (I, J). Arrows point to 
the cochlear duct in H-J. The endolymphatic sac in E, F, G and J was present but did not fill with paint. cvg, cochleovestibular 
ganglion; ov, otic vesicle; nt, neural tube; pom, periotic mesenchyme. Scale bar in D is 200 μm, scale bar in F is 350 μm.Page 7 of 12
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gest that Tbx1 and Brn4 act in concert to regulate RA
activity in the POM, consistent with increased mesenchy-
mal RA signaling observed in Tbx1-/-embryos.
Discussion
Distinct roles of Tbx1 in the otic vesicle and POM
During inner ear development, Tbx1 is expressed in the
ventral mesenchyme cells that surround the otic vesicle
and give rise to the cochlear capsule. TCre-KO embryos
displayed malformations in both the otic capsule and
membranous labyrinth, with ventral structures most
severely affected. These results indicate that Tbx1 expres-
sion in the POM is essential for development of the epi-
thelial structures of the inner ear. There are two potential
explanations for this phenotype. It is possible that meso-
dermal Tbx1 is required for proper formation of the otic
capsule, and abnormal condensation or differentiation of
the POM prohibits proper outgrowth and coiling of the
cochlea. An alternative, yet not mutually exclusive, expla-
nation is that ablation of mesodermal Tbx1 disrupts sign-
aling to the cochlear epithelium, altering the expression of
genes critical to the formation of the membranous laby-
rinth and subsequently the otic capsule. This latter sce-
nario is supported by the presence of physical
malformations and a decrease in cell survival in the otic
vesicle of TCre-KO embryos prior to capsule formation.
We provide evidence that signaling to the otic epithelium
occurs via RA, and propose that proper control of RA
activity by the POM domain of Tbx1 is required for nor-
mal development of the inner ear.
The data from this and previous studies support distinct
and independent roles for Tbx1 in the otic vesicle and
POM, despite the close proximity of these tissues during
development. Expression of Tbx1 in the otic vesicle func-
tions just after induction of the otic placode, and is
required for specification of neural versus sensory cell fate.
This is accomplished via inhibition of neurogenic genes
such as Ngn1 and NeuroD, while promoting expression of
sensory markers such as Otx1 and Bmp4 [14,16]. In con-
trast, expression of Tbx1 in the POM does not appear to be
required until after the major patterning events of the
inner ear have occurred and the otic vesicle has acquired
its axial identities. Indeed, sensory and neurogenic mark-
ers are expressed normally in the otic vesicle of TCre-KO
embryos at E10.5. Due to the hypomorphic nature of the
TCre-KO allele, we cannot exclude the possibility that suf-
ficient Tbx1 expression exists at earlier stages to obscure a
subtle patterning phenotype. However, lack of patterning
defects in Mesp1Cre-KO using a different floxed allele
[17,24] embryos argues against this alternative.
Genes interacting with Tbx1 in the POM
We have previously identified a genetic interaction
between Tbx1 and Brn4 in the POM [16,19]. Mice null for
Brn4 display a reduction in the number of cochlear turns,
although the penetrance of this phenotype is incomplete
and is less severe than the cochlear defects observed in the
TCre-KO mutant [12]. Brn4 protein expression was
reduced in TCre-KO embryos at E10.5, indicating that
Tbx1 may regulate transcription of Brn4. Alternatively, it is
possible that Brn4 expression is lost due to a reduction in
the number of POM cells in the TCre-KO mutant.
Although no changes in proliferation or apoptosis were
observed in the POM at E11.5, Tbx1 is expressed in only a
subset of cells in the POM and confining the analysis to
Tbx1-expressing mesenchymal cells may reveal a prolifer-
ation defect in this tissue. Nevertheless, the completely
penetrant cochlear phenotype observed in Brn4-;Tbx1+/-
embryos together with the absence of detectable defects in
Brn4+/-;Tbx1+/- embryos suggest that these genes act in par-
allel pathways.
As previously mentioned, Shh secreted from the ventral
midline regulates expression of Tbx1 in the POM, and
Tbx1 is expressed in the ventral POM closest to the source
of Shh (the notochord and floor plate). We hypothesize
that Tbx1 functions in parallel with Brn4 to modulate gene
expression in a critical subset of POM cells on the ventral
border of the otic vesicle, and that interactions between
these cells and the otic epithelium are necessary for proper
cochlea formation (Fig. 7). Recently, a model was pro-
posed in which Shh functions in two phases to regulate
cochlear duct morphogenesis [6]. In early development,
Shh secreted from the ventral midline regulates patterning
of the ventral otic vesicle by antagonizing the Gli3 repres-
sor protein. In the later phase, Shh promotes outgrowth of
the distal portion of the cochlear duct via recruitment of
Gli activators. The cochlear defects seen in the mutants
analyzed in this study indicate that Tbx1 and Brn4 likely
act downstream of Shh in this second phase of develop-
ment. Supporting this is the expression of mediators of
Shh signaling, Ptc1, Gli1, Gli2 and Gli3, in the ventral POM
[6]. In addition, the forkhead box transcription factors
Foxc1 and Foxc2 are known to directly activate Tbx1
expression in the POM by binding to an enhancer, down-
stream of Shh [29]. This places these Fox genes down-
stream of Gli signaling but upstream of Tbx1.
Tbx1 may regulate RA activity
Our data support a model in which Brn4 and Tbx1 act
cooperatively on the same downstream target(s) to pro-
mote proper growth of the cochlear duct. Altered expres-
sion of Cyp26 genes in the POM of mutant embryos
indicates that RA may be one of these targets (Fig. 7). In
the ear, RA activity is regulated via metabolizing enzymes
that are expressed in both the otic vesicle and the POM
[28]. Expression of the Raldh genes is mainly confined to
the epithelium, while the Cyp26 genes localize to the mes-
enchyme [20]. Expression of both Cyp26a1 and Cyp26c1
was altered in the POM at E10.5 and E11.5 in TCre-KOPage 8 of 12
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embryos at E12.5. These data indicate that Tbx1, and to a
lesser extent Brn4, are required to maintain expression of
Cyp26a1 and Cyp26c1 in the POM during inner ear devel-
opment. Loss of Tbx1 in the POM also caused a decrease
in cell proliferation and an increase in apoptosis in the
otic epithelium at E11.5. These defects were not localized
to the ventral epithelium, but were instead observed
throughout the entire otic vesicle. While unexpected, this
result may be due to the diffusible nature of RA, and pro-
vides an explanation for the reduction in size seen in dis-
sected otic vesicles of TCre-KO embryos at this stage.
Alternatively, it could be due to normal cell movement
within the tissue.
Mouse mutants in which RA activity is increased during
embryogenesis, either by null mutation of the Cyp26
genes or exposure to ectopic RA, display abnormal seg-
mentation of the hindbrain [30-32]. Without the proper
external cues emanating from this tissue, otic vesicle pat-
terning and morphogenesis is abnormal [33]. Because of
these early defects, however, the function of RA at later
stages of ear development is not as well understood.
Ectopic RA activity due to decreased catabolization could
lead to the cochlear malformations seen in TCre-KO and
Brn4-;Tbx1+/- embryos via RA action on the otic vesicle,
POM or both. Cyp26 enzymes expressed in the POM may
function to inactivate excess RA produced by the epithe-
lium, preventing abnormal regulation of RA target genes
in the otic vesicle. Supporting this, adminstration of
ectopic RA after otic specification is complete results in
hypoplastic, malformed inner ears in both mouse and
chick [34,35]. In addition, genes important for cochlear
development were shown to be inhibited by increased RA
levels [36,37]. It is also possible that genes in the POM are
responsive to excess RA, leading to defects in remodeling
around the growing cochlear duct and preventing proper
cochlear coiling. This has been demonstrated by the inhi-
bition of capsule chondrogenesis following RA treatment
of cultured otic explants of mouse embryos [38].
Conclusion
In summary, we have further described the genetic inter-
action between Tbx1 and Brn4 and shown that these genes
regulate RA catabolizing genes in the POM during inner
ear morphogenesis. Our results add to the evidence sup-
porting a tissue non-autonomous role of the POM during
development of the inner ear. Future studies will focus on
gaining a better understanding of the relationship
between Tbx1 and RA signaling in inner ear development,




The generation of the Tbx1 null allele and the Tbx1flox
allele have been previously described [39]. T-Cre mice
were obtained from Dr. Mark Lewandoski at the NIH [8]
and crossed to ROSA26 reporter mice (Jackson) to analyze
Cre activity. To generate T-Cre;Tbx1flox/- embryos (TCre-
KO), T-Cre transgenic mice were crossed to Tbx1+/- mice on
a mixed C57Bl6/Swiss Webster background to obtain T-
Cre;Tbx1+/- mice. These mice were crossed to Tbx1flox/flox
mice on a mixed genetic background. Tbx1+/- littermates
were used as controls in all experiments. Mice were geno-
Expression of Cyp26 genes is altered in TCre-KO embryosFigure 5
Expression of Cyp26 genes is altered in TCre-KO 
embryos. Cyp26a1 and Cyp26c1 expression detected by 
whole mount in situ hybridization at E10.5 in control and 
TCre-KO embryos (A-H). The plane of section in B, D, F and 
H is marked in A, C, E, and G, respectively. Cyp26a1 expres-
sion in the lateral POM (arrows in B) is absent in TCre-KO 
mutants (arrows in D), and appears shifted to a more ventral 
position (compare A an C). Cyp26c1 expression is strongly 
reduced in the mesenchyme of TCre-KO mutants (compare F 
and H), but 1st arch expression is unaffected (asterisk in E and 
G). At E11.5, Cyp26a1 expression remains shifted medially in 
TCre-KO mutants compared to controls (I-L), especially in 
posterior sections through the growing cochlear duct 
(arrows in J and L). Cyp26c1 is strongly reduced in the ventral 
POM at this stage (M-P), but remains present in the otic epi-
thelium (arrows in M and O). A dotted circle outlines the 
otic vesicle (ov) in A, C, E, G. Scale bar in P is 200 μm and 
applies to all panels except A, C, E, G.Page 9 of 12
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gagtgatgag 3' and 5' accaagtgacagcaatgctg 3') and the
Tbx1flox allele (5' tcttcttggggctgtagact 3' and 5' tgactgtgct-
gaagtgcatc 3').
To generate Brn4 and Tbx1 compound mutants, Brn4
hemizygous males or heterozygous females in a mixed
genetic background were crossed to Tbx1+/- mice main-
tained on a C57BL/6 background [19]. These offspring
were intercrossed to obtain the following genotypes:
Brn4+/-, Tbx1+/-, Brn4+/-;Tbx1+/-, Brn4-/- (or Brn4-), and Brn4-
/-(Brn4-);Tbx1+/-.
Immunohistochemistry
Embryos were isolated in cold PBS followed by fixation in
4% PFA overnight at 4°C, ethanol dehydration and
embedding in paraffin wax. Seven μm thick sections were
treated with either polyclonal rabbit Tbx1 antiserum
(Zymed) 1:500, affinity-purified rabbit polyclonal anti-
Brn4 antibodies [40]1:400, anti-cleaved Caspase 3 (R&D
Systems) 1:1000, or anti-phospho-Histone 3 (Upstate)
1:200 in TBS/0.1% Triton X-100/5% goat serum/2%BSA.
Sections were incubated for 1 h at room temperature and
visualized with a biotinylated goat anti-rabbit IgG conju-
gate (1:200; DakoCytomation), avidin-biotin complex/
HRP formation (DakoCytomation) and DAB/chromogen
reaction (DakoCytomation). For histology, sections were
stained with hematoxylin and eosin.
RNA in situ hybridization
Analysis of Tbx1 expression was performed using a full-
length mRNA probe cloned by PCR into pCRII-TOPO
(Invitrogen). A probe specific to the region deleted in Tbx1
conditional mutants was also generated and exhibited
similar results. The remaining probes were either obtained
as previously described [16] or generated as approxi-
mately 1 kb PCR fragments amplified from E13.5 mouse
cDNA. All forward primers contained T3 polymerase
priming sequence and all reverse primers contained T7
polymerase priming sequence. PCR products were puri-
fied by the PCR Purification Kit (Qiagen). Anti-sense RNA
was in vitro transcribed and labeled with the T7 RNA
polymerase (Roche) and DIG RNA Labeling Mix (Roche)
using the Digoxigenin labeling method. Labeled RNA
probes were purified by LiCl2 precipitation and re-sus-
pended in 20 μl of RNAse-free water (Gibco). In situ
hybridization was performed whole mount or on sections
using standard methods as previously described [41]. To
generate histological sections following whole mount in
situ hybridization, embryos were dehydrated through a
graded ethanol series (70% EtOH for 5 minutes, 95%
EtOH for 10 minutes, 2 times 100% EtOH for 5 minutes,
100% EtOH for 10 minutes, 2 times Xylene for 15 min-
utes), embedded in paraffin wax and sectioned at a thick-
ness of 10 μm.
Inner ear paint-fill
Embryos were isolated at E15.5 in PBS, cut below the fore-
limbs and placed in Bodian fixative (5 ml glacial acetic
acid, 5 ml 37% formaldehyde, 15 ml H20, 75 ml 100%
EtOH) overnight at room temperature. Embryos were
dehydrated in 100% ethanol overnight and cleared in
methyl salicylate. Prior to injections, embryo heads were
hemisected and the brain was removed. The inner ears
were visualized by injecting 0.2% white Correction Fluid
in methyl salicylate into the membranous labyrinth. The
micropipette was inserted into the superior ampulla or
the utricle depending on the ease of visualization of the
lumen.
Cyp26c1 expression is reduced in Brn4-;Tbx1+/- embryosFigure 6
Cyp26c1 expression is reduced in Brn4-;Tbx1+/- 
embryos. Transverse sections through the cochlear duct (c) 
probed for Cyp26c1 (A-C, E-F) or Tbx1 (D) in Tbx1+/-, Brn4- 
and Brn4-;Tbx1+/- embryos at E12.5. Cyp26c1 expression is 
reduced in the ventromedial POM surrounding the cochlear 
duct of Brn4-;Tbx1+/- embryos (C and F) compared to Tbx1+/- 
(A) and Brn4- (B and E) embryos. Tbx1 is expressed in this 
same region (D) and overlaps with Cyp26c1 expression. 
Expression of Cyp26c1 in the otic epithelium is unaffected in 
Brn4-;Tbx1+/- embryos. Scale bar is 200 μm.Page 10 of 12
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Skeletal staining of E17.5 embryos was performed as pre-
viously described [42]. Embryos were dissected and the
skin removed followed by fixation in 100% EtOH over-
night. Bone and cartilage were stained overnight with Ali-
zarin red and Alcian blue, respectively. Loose tissue was
removed by digestion in 2% KOH overnight, followed by
destaining in 1% KOH/20% glycerol for 4–7 days.
Embryos were transferred to 20% glycerol/20% EtOH
overnight, followed by storage in 50% glycerol/50%
EtOH.
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